There was no significant difference in the levels of factor XI1 between sick newborns and normal age-matched controls, 31-though the levels of both groups were lower than normal older children. Detailed coagulation studies on 44 sick infants revealed 11 to have disserninated intravascular coagulation (DIC). In those with DIC, the mean Hageman factor was 2070 and in those without DIC, 25% (P > 0.05). Rabbits given a constant infusion of Iysozyn~e (which inhibits factor XII) shosved lahoratory evidence of endotosin-induced DIC. The data suggest that neither reduced factor XI1 levels nor HagenIan factor inhibition provided protection from DIC. The data further suggest that other coagulation pathways might be involved in order to elicit the DIC.
Speculation
Since IIageman factor activation is thought to be involved in initiating the coagulation nlechanisrn and activation of fibrinoIytic, kinin, and conlplen~ent systenls and therefore rnay be involved in basic pathophysiologic reactions, this study was undertaken to determine whether physiologic reductions in this factor might be protective in any way. Although it was found that newborns had lower factor XI1 levels than older chiltlrcn or adults and that the levels were lower in the younger infants and were therefore thought to he due to a developmental delay, no protection from the developnlent of acquired coagulopathies could be detected. i \ significant number of sick neonates were found to have a variant form of DIC (reduced plasnla factors 11, V, VIII, and fil)rinogen, l)ut nor~nal platelet counts illstead of thro~nI)ocytopenia). It is speculatetl that these infants' platelets were not responsive to the DIC-provoking event due to a developnlental platelet dysfunction.
The role of Hageman factor (coagulation factor X11) in activating tlie intrinsic o r plasma coagulation n~eclianism is well known. hlore recently. factor XI1 has been reported to he involved directly o r indirectly in activating tlic fibrinolytic, kinin, and complement systems (7, 19) . Thus. it has hccn postulated that factor XI1 and its activation may play a pivotal role in the initiation of many pathophysiologic reacttons ranging from inflan~niation to shock. Ne\vhorn infants are known to have reduced Hageman factor lcvels and normal adult levels are not achieved until 7-13 days of age ( 1 , 8) . The biologic significance of this reduction in Hageman factor is not known.
Experimental and hunian data suggest that activation of factor XI1 may be instrumental in producing the coagulopathy of DIC (9-1 1). Pretreatment of rabbits with lysozyrnc, which prevents the activation of Flagernan factor (16), reportedly protects tlie aninials for developing liquoid-induced DIC (13) . The purpose of this study \\,as to investigate the levels of factor XI1 and their role in sick n e~h o r n s with ;~ssoci;~ted c~;~g u I o p~~t I i i e s and to study the effect of factor XI1 inhibition o n endotosin-induced DIC in rabbits. The data indicate that neither reduced factor XI1 levels nor H;~gcman factor inhibition providcd protection froni DIC. The data also suggest that in both the esperi~nental niodel and sick neonates another coagulation pathway must be involved in order to elicit the DIC.
hiA'I'ERIALS AND hlETl1ODS 3 5 <37 wks Gestational Age , 15 No hloocl proclucts had been given hefore the initial study. > 60 Hospital by st:~ndard hematologic technicluc. Citratecl platelet poor plasma was used for assays of factors XI1 (23) . VIII (24), V Factor XI1 Levels (22), I1 (1 7). arid fibrinogen (20) . In some instances, fibrinolytic (% of normal) assays were performed and consisteel of plasma plasminogcn and Fig. 1 . Factor XI1 levels in norni;~l full term and premature ne\vborns. plrlsnninogen activator levels by employing a fibrin plate techriirlue (3).
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ANlhlAL STUDIES
Normal Sick P Rabbits, Ci~lifornia strain, of either scs. ~vcighing 1 .0 kg \verc used. E.scl~o.icl~irr coli endotosin 01 113., (Difco Laboratories. Detroit, Mich.) solutions were prepared fresh daily in normal saline solution. Lysozyme (Nutritional Biochemical Corp.. Clcvcl:~nd. Ohio) \\as dissolved in sterile normal saline. Whole blood \vns obtained from the rabbits by two syringe technique and anticoagul;~tcd in a ratio of 1 volume 3 . 8 % sodium citrate to 9 volumes \\hole hlood. T h e anticoagulated blood was centrifuged at 8,000 rpm for 2 0 min at 4O to ohtain platelet-poor plasmit. l'he plasma \\,:IS usccl for partial prothromhin time (PTT) (24). prothrombin timc (18) . ancl assays of factors X1I. VIII. V , 11, and fibrinogen by methocls describccl under "Hum a n Stuclies." Platelet counts \\,ere performeel o n ~v h o l e hlood using pli:~se microscopy (2). Uecausc of the rapid plasma disappearance rate o f Iysozyme. adcclu;lte lcvcls could be achi;;,rcl only by using constant infusion by way of a FI:~rvnrd p u m p . 7'hc model consisted of a young rabbit with a Teflon catheter in the estcrnal jugular vein \vhich was usecl for tlic constant infusion of Iysozymc and 21 sirnil;lr c:~thetcr pl:~ced in the ci~roticl artery \vhicli \\,as used for hlood sampling. This preparation stl~yed intact ancl thrombus free for up to 6 lir. It \vas found that an infusion of 2 0 rng/kg/rnin of Iysozyme regularly prolongeel the PTT. T h e effect \\,:IS noted Ivithin 10 niin and could be maintained indcfi~iitely. Simil:~rly treated animals using saline o r phospli:~te-buffcreel saline showed n o change in their co:~gul;ltion studies.
RESULTS

CLINICAL STUDIES
Nornial ancl sick neonates \\,ere grouped according to gestational ages; ;I full tern1 infant was defined as greater than and a premature as less tli;ln 3 7 \veeks gestational age. Of the sick infants, 7570 of problems were due to respiratory distress syndrome (RDS). 6 % to sepsis, and 10% to miscellaneous causes such as abruptio placentae, pncunionia, hyposia secondary to fetal clistress, and so forth Figure 1 demonstrates the clistribution of tlic factor XI1 lcvcls in the normal full term and prcmaturc infants. A s can be seen. 7 3 % of the premature infants had 30% o r less factor XI1 levels \vIicrc:~s 8 2 % of the full term infants clcrnonstratccl levels of factor XI1 above 3 0 % . T h e data suggested that the sniallcr the infants, the lower the factor XI1 levels. Thus, in three gestational age groups (37-32, 33-37, and 27-33 \vceks) the factor XI1 levels were 4 7 % & 4 in 21 infants, 3 3 % 2 4 in 13, and 2 7 % 2 6 iin 1 0 . A coniparison of the factor XI1 levels in both normal and sick newborns is depicted in Table  1 . There was n o significant difference hct\vecn tlie normal and sick infiunts in either group. Although full term infants h:~d higher factor XI1 lcvcls than prcnnaturcs and the normal infants had higher lcvcls than sick infants, the data was not significantly different bet\\~ecn these groups. Detailed coagulation analysis was performed o n 4 3 of the 7 7 sick neonates. T h e largest number of patients werc found in the respiratory distress syn- ' The llagcman factor is espressc~l as a percentage of normal. Numhers in parentheses are nurnl>cr o f nc\\horns.
drome and the results arc s h o~v n on Table 2 . l'here were 3 2 such infants and the results of all tlic infants are shown in the first column of the table. T h e R D S infants werc arbitrarily divided into those u.ith thromhocytopenia anel a group with reduced factor VIII levels. N o significant difference in the factor XI1 levels was noted in thcsc groups. Whcn the infants were suhdividcd on the basis of the severity of R D S , it was found that the factor XI1 level \vas lower (17% activity) in the severe group ( 2 0 infants) than in the patients n.ith ~iiild to moderate ( 1 3 % factor XI1 activity) disease ( I 2 infants). Whcn all of the sick neonates \vith hypofibrinogc~ie~ini:~ were studied, it was found that they clustered into two groups. Grorrp I , tvhicln consisted of I3 infants. had reducccl factor VIII levels and grolrp I1 \v;~sconiprised of 14 infants ~v h o demonstrated normal to incre:~sed factor VIII activity. T h e results are shown in T:thle 3 . A s can he seen. the grorip I infants demonstrated a more severe coagulop:~tliy with regard t o factors 11. V , V111, and XI1 \\hen coniparcd to the grorcp I1 infants. There was no difference in the types of disease entities seen within the t\vo groups. (111 grorrp I there were eight cases of R D S and asphysia. three habies born of abruptio placentae. one pneumonia, o n e sepsis, and o~i c congenital heart disease case. In grorrp 11, there \\ere cight cases of R D S with asphysia, two with abruption, anel four n i t h pneumonia.)
Of all tlie sick infants. 1 1 were found to tii~ve classic disseniinated intravascular coagulation (c#.g.. tlnrornhocytopcnia with reduced factors 11. V. VIII. and fihrinogcn). In those with DIC, the factor XI1 lcvcls were 90% activity and those without were 1 5 sf1 ;~ctivity.
The time of obtaining the hlood samples for factor XI1 assay in the sick infants who [lid not receive p l~~s n i ;~ o r \vholc blood transfusion bcforc study \\.;IS not critical. In 00 determinations. the factor XI1 levels were 3 0 % if the samples wcrc obt:iinccl hct\vccn 0 ancl I 1 hr after birth. 25% bcttvcen 1 1 and 2 4 hr. and 24% bet\vee~n 24 ;111d 4 8 hr.
Twenty infants were given plasma tr:~nsfusions after the initial studies were performed. Sistecn of these could be evaluateel in follo\v-up. Ho\vcvcr. the data did not give : I clue to the possihle half-life of the factor XII. In all infants. the prctransfusion factor XI1 lcvcl \vas 2 7 % and the post-tr:lnsfusion lcvcl was 4 9 % . T h e post-tr;~~nsfusio~i levels were determined at v:~ri;tble timcs.hut usually within 3 8 h r after the infusion. T h e data suggestccl that the baseline factor XI1 levels were reached 7 2 h r after the previous transfusion. ' Number of neonates. ' Range.
Fibrinolytic studies in 20 premature and 20 full term infants revealed n o significant differences in plasrninogcn levels (I .O unit t 0.1 versus 0.7 urnit If; 0. I ) o r plnsminogcn activator content (I I 0 nlm' t 22 versus 5 0 mm' IT 15). Factor XI1 levels in over 100 older children and adults have consistently been in the range of 75-100% (00% 5 10).
ANIhlAL hlODEL FOR t1AGEhlAN FACTOR INHIl3ITION
Pooled, citratcd platelet poor plasma \\.as obtained from normal rabbits. Saline o r various concentrations of Iysozymc were added to plasma aliquots. Aftcr appropriate incubation pcriocls. the partial thronnboplastin times and prothrombin times \\,ere calculated. Compared to saline controls. significant prolongations of only the P T r \\,as sccn with Iysozyme. The P T T for a mixture of saline and rabbit plasma \\.as 7 1 scc. whereas plasma plus Iqsozyn~e was greater than 250 5ec. Adding normal plitsma to the lysozynic-treated rabbit plasma partially corrected the abnormality; ho\vcver. adding human plasma \\hich was congenit:tlly deficient in factor XI1 did not provide correction. By using the infusion rate of 3 0 mg/kg/min o r greater o f Iysozyme. the P7'T was significantly prolonged in normal rabbits, and, there \\.as n o change in either the plasma prothrombin timc at the same timc the P T T \vas prolonged o r in the platelet count, factors 11, V. o r VIII levels. Ho\vever, H:tgem:tn factor activity fell 43-61 76 from baseline. Aftcr discontinuing the infusion. Hi~geman factor activity returned to normal within 20 win. In the endotoxin cspcri~nents, rabbits were prepared with 0.1 mg/kg elldotoxin given intravenously. Twenty-four hours later, the animals \\.ere infused wit11 either sterile normal saline o r lysozyme. The infusions were continued for 7 hr. A second cndotoxin injection of the same clurrntity was given 15 min after the start of the infusion. that is, at a time \\hen the P T T \\,as grossly prolo~lgcd in tlie Iysozymc-trcatccl anirn;~ls. Blood \\.as then obtainccl at 4 hr for nicasurcment of the white blood cells. platelets, factor XII, and fibrinogen concentration. T h e results arc shown in Table 4 . A s can be sccn. lysozyme infusion prevented the fall in factor XI1 Icvcls. but did not influence enclotosin-induced leukopeni:~. thromhocytopc11i:1, o r fibrinogen reduction.
DISCUSSION
I<cduced factor XI1 lcvcls in humans can either be due to a deficiency of this factor (8) or intravascul;tr activation with subsequent reduction, as suggested by hlason and his associates (9, 10). The finding that normal neonates have reduced factor XI1 lcvcls could be interpreted. therefore, its either clue to physiologic clcvclopmcntal delay o r as evidence of activation of the intrinsic coagulation mcch:tnisnn. 7'hc data in this study indicate that both normal and sick neonates had similar factor XI1 levels. In addition. even in those infants \vho had manifested severe activation of the coagulation mechanism. i.c,., clisscminatcd intravascular coagulation, shotved no significant diffcrcncc between the factor XI1 lcvcls in that syndrome versus cithcr normal infiunts or i~nfants who had other coagulopathics. These results \vould suggest that the reduced lcvcls in n e \~b o r n s arc predominantly due to a dcvclopmcntal dalay and do not manifest activation of the intrinsic coi~g,ulation mcchanism. Like the rabl:its, the reduction in factor XI1 In the newborns did not seem to provide protection ag:~inst rrccluircd induced coagulopathics, pi~rticularly DIC. The fact that a consumption coagulopathy could inclced develop in the neonate wit11 Ilagemitn factor deficiency and that the level of factor XI1 did not necessarily decrease during the :rctivation phase strongly suggests that the neonate. like the lysozyme-treated rabbit, can activate his coagulrttion patln\vay.
In this study, an itr vi~lo model for inactivating Ijagcnian factor was developed in rabbits. Contrary to the experience \\.it11 liquoid-induced D I C (14) , endotoxin-ind11cec1 D I C could not be prevented in the Iysozymc-trcatccl animals of this study. I'rcvious investigators h:tve suggcstccl t1i:tt cntlotoxin :tctiv;ttes Hagemitn factor arid this \\.as the trigger for the mechanism of activation o f tlie intrinsic coagulation mechanism (1 1 , 12) . In addition, intravascular coagulation was reported not to occur in I ' a b l c 4. L j . s o z j t t r c~ itrfirsiotr itr c,~rtloto.uitl-rrc,(~tc~(l rtrhhir. sl :' hle;ln 2 S l l h l .
the f o n l \\it11 either licluoid o r e n t l o t o s i n ( 7 5 ) . I t is k n o w n t h a t t h e f o w l is c o n g c n i t i~l l y cleficicnt i n f a c t o r XII. I l o \ v e v e r . S h c n cpt (11. ( 2 3 ) , by using a n antibody a g a i n s t factor V I l I anel t l i e r e f o r c
iriliihiting the e a r l y p l i a s e s of intrinsic co;~gulation. found t h a t i11tr:~vascular c o a g u l :~t i o~i coulcl be intlucetl by c n d o t o s i n in r a hbits ;lncl s u g g c s t c t l t h a t the cndotosin probably t r i g g e r s c l o t t i~i g I? b o t h t h e i n t r i n s i c and e s t r i n s i c systems. platclcts i n the f a c e of rccluccd f a c t o r s 11. V. VIII. a n d fihrinogcn. S i n c e t h e s e inf;~!its hacl n e i t h e r licrnol>hili:t n o r e v i d e n c e o f a h y p c r f i b r i~i o l y t i c s t a t e . t h e elatti c o~~l d be i n t e r p r e t e d as i n d i c a ting :I f o r m o f t l i s s c m i n ;~t c t l i n t r a v ;~s c u l a r c o ;~g u l a t i o n \vitIiout tlic classic p l ;~t e l c t c h a n g e s . Since no a t t e m p t \ v ;~s m ;~c l c to stucly t h e half-life o f t h e ~> l a t c l c t s i n tlicsc i n f~~n t s . it is poszil>lc t l i a t p r ot l u c t i o~i o f 1~1;1tcIcts \vas k c e p i~i g up \\.it11 t h e d e s t r u c t i o n . I t is k n o w n tIi;~t h u~i i a n n e o n a t e s . p a r t i c u l ;~r l y p r c m a t u r c s . h a v c : I t r a n s i e n t b u t tlcfinitc platelet clysfunction so t h a t an a l t c r~i a t i v c v i e w coulcl bc t h a t tIironihocyto1~criii1 tlicl n o t t l e v c l o p in thcsc l'his paper reports the investigation o f a casc associating grotesclue skeletal dcforriiities, selective hjpoplasia o f riiuscle f i h e r types I arid IIA. aritl a decrease i n skeletal niineral plus increased skeletal resorption. T h e investigation also iticlutlctl adniinistration o f synthetic salnion calcitoniri. a hornlone that reduces bone resorption. T h e patient, a 1 0 -j ear-oltl feniale. presented w i t h foresliortericcl, clawlike haricls ant1 feet, j o i n t stiffness \ r i t h rontractures, niarketl niuscle atrophy, arid severe -j o i n t pain. Radiologic survey revealecl riiuscle atrophy, osteoporosis a n d cpipti,seal osteol~sis. 47Ca turnover was acceleratetl.
A n u~i i h c r o f i n v c s t i g :~t o r s h a v e s t r c s s e t l t h e i m p o r t a n t rolc t h a t t h e blood p l ;~t c l c t s m a y h ;~v c i n t r i g g e r i n g t h e m e c l i a n i s n i for i~~t r a \~;~s c u l a r c l o t t i n g . It is certainly c o n c e i v a h l c t l~a t e n c l o t o x i n ;~c t i v a t c s the e s t r i~i s i c c o a g u l a t i o~~ ~i i c c h a n i
. --hluscle biopsy revealed a population o f hypoplastic riiuscle fibers, 10-22 p r i i in dianicter, scattered sirigly o r i n sniall groups anlong a n i a j o r i t y o f larger n i o r p h o l o g i c a l l~ norriial filjers. XI $ ofibrillar A'l'l'ase stains sho\r.ed that a l l types I antl 1 I A fibers present \rere lijpoplastic, a n d a l l large fibers present were t j p e 11B. I.:lectron microscopic stuclg o f the skeletal ~i i u s c l e slio\r.ecl n o r n l a l niyofihrils b u t vacuolated ~i i i t o c t i o n t l r i a t r i t l i disorganized cristae i n the lijpoplastic filjers. Synthetic saltlion calcit o n i n given at 2 h l l l C units/kg 3 clays a \reek proclucrtl a riiarkecl iniproveriient i n I)one p a i n arid reducctl urinary excretion o f Iliac crest biopsy bef o r e ralcitonin revealetl increased uncalcifietl bone niatrix ant1 increased osteoclastic activity. A f t e r 3 niontlis o f calcitonin there was a decrease in t h e aniount o f uncalcified n i a t r i s a n d a n apparent decrease i n osteoclastic activity. S k i n biopsy was nornial. Speculation
O n e niay specul:~te as to the rcl:itionsliip I)ct\recn t h e ~i i u s c l c a n d bone abnormalities in the present case. J o i n t contractures likely that the j o i n t deforniities arc at least i n p:trt relatctl t o the niuscle I i j l~~p l a s i a a n d \\eakness. T h e osteonialacia ant1 epipliyse:ll ostcolgsis, on the other Iioritl, have n o t Ijecn reportccl i n association w i t h otlier t j p e s o f congenital tiiilsclc tlisease, ancl appear tiiucli t o o severe t o I)e secontlary plienoriic~i:~. 'I'he selective niuscle fiber lijpopl;~sia ancl severe osteonialacia are apparently t w o associatecl aspects of o n e clinical sj~iclroriie. \Vhether tlie ~i i i t o c h o n d r i a l abnormalities n o t c t l in the ~i i u s c l e rellect tlic u n t l e r l j i n g nietaholic clefect o f tliis syntlroliie relliains t o b e i nvestigated.
\\'c report it girl of Oricntal-Arncric;~~~ Negro descent \vho was foulld to have the clinic:tl features of forcshortcncd. cl:t\\likc h:tnds and feet. joint stiffness. and contracturcs \vitli scvcrc joint pain ancl musclc atrophy. This cliaractcristic clinical picturc is cxplainetl by : I sclcctive muscle fiber hypoplasia affecting typcs I a t l d IIA fibers. ;tssoci:ttctl tvitli : I rn;~rkcd ostcolytic 1 x 0~s~. To our kno\vlcdgc. tliis is tlie first time that c:trpal :tntl t:trs:tl osteoIysis has heen associ;tted wit11 :I sclcctivc musclc fihcr hypoplasia. A IO-ye:~r-old girl \v;ts born by normal vaginal dclivcry after a n uncomplic:ttcd full term pregnancy. The mother is Oriclltal ancl tlic f;~tllcr is a11 A~i i c r i c :~~~ Negro. The family liistory rcvc~tled a mothcr. t\vo sisters. :tnrl ;I brother in good health. The father h:td muscle \vcakncss during childhood and ~~dolescence. and lie \\as refused itcllnission to the army hcc:tusc of it. A recent physical examination rcvcalccl normal musclc strength and mass. Hc rcfused a muscle biopsy. Tlicrc was n o history o f musculo-
